These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15312962)

  • 1. MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels.
    Fenoglio C; Galimberti D; Lovati C; Guidi I; Gatti A; Fogliarino S; Tiriticco M; Mariani C; Forloni G; Pettenati C; Baron P; Conti G; Bresolin N; Scarpini E
    Neurobiol Aging; 2004 Oct; 25(9):1169-73. PubMed ID: 15312962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians.
    Pola R; Flex A; Gaetani E; Proia AS; Papaleo P; Di Giorgio A; Straface G; Pecorini G; Serricchio M; Pola P
    Exp Gerontol; 2004 Aug; 39(8):1249-52. PubMed ID: 15288699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCP-1 A-2518G polymorphism: effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels.
    Galimberti D; Venturelli E; Villa C; Fenoglio C; Clerici F; Marcone A; Benussi L; Cortini F; Scalabrini D; Perini L; Restelli I; Binetti G; Cappa S; Mariani C; Bresolin N; Scarpini E
    J Alzheimers Dis; 2009; 17(1):125-33. PubMed ID: 19494437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
    Bian JT; Zhang JW; Zhang ZX; Zhao HL
    Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association of the MCP-1 promoter A-2518G polymorphism with bipolar disorder in the Korean population.
    Roh MS; Lee KY; Joo EJ; Lee N; Kim YS
    Neurosci Lett; 2007 Oct; 427(1):1-5. PubMed ID: 17928143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
    Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease.
    Combarros O; Infante J; Llorca J; Berciano J
    Neurosci Lett; 2004 Apr; 360(1-2):25-8. PubMed ID: 15082170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.
    Rodríguez-Rodríguez E; Sánchez-Juan P; Mateo I; Llorca J; Infante J; García-Gorostiaga I; Berciano J; Combarros O
    Acta Neurol Scand; 2007 Dec; 116(6):409-12. PubMed ID: 17986101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
    Arosio B; Trabattoni D; Galimberti L; Bucciarelli P; Fasano F; Calabresi C; Cazzullo CL; Vergani C; Annoni G; Clerici M
    Neurobiol Aging; 2004 Sep; 25(8):1009-15. PubMed ID: 15212825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
    Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
    Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study.
    Altamura AC; Mundo E; Cattaneo E; Pozzoli S; Dell'osso B; Gennarelli M; Vergani C; Trabattoni D; Arosio B; Clerici M
    Neuroimmunomodulation; 2010; 17(2):126-31. PubMed ID: 19923858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of interleukin-1beta polymorphism with Alzheimer's disease in the Jewish population.
    Rosenmann H; Meiner Z; Dresner-Pollak R; Kahana E; Aladjem Z; Grenader T; Wertman E; Abramsky O
    Neurosci Lett; 2004 Jun; 363(2):131-3. PubMed ID: 15172100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer's disease in Italians.
    Geroldi D; Minoretti P; Bianchi M; Di Vito C; Reino M; Bertona M; Emanuele E
    Neurosci Lett; 2005 Oct; 386(3):176-8. PubMed ID: 16002217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
    Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
    J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A promoter polymorphism in the monoamine oxidase A gene is associated with the pineal MAOA activity in Alzheimer's disease patients.
    Wu YH; Fischer DF; Swaab DF
    Brain Res; 2007 Sep; 1167():13-9. PubMed ID: 17692293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.
    Galimberti D; Fenoglio C; Lovati C; Venturelli E; Guidi I; Corrà B; Scalabrini D; Clerici F; Mariani C; Bresolin N; Scarpini E
    Neurobiol Aging; 2006 Dec; 27(12):1763-8. PubMed ID: 16307829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
    Galimberti D; Schoonenboom N; Scheltens P; Fenoglio C; Bouwman F; Venturelli E; Guidi I; Blankenstein MA; Bresolin N; Scarpini E
    Arch Neurol; 2006 Apr; 63(4):538-43. PubMed ID: 16606766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between Interleukin-18 gene promoter polymorphisms and onset of Alzheimer's disease.
    Segat L; Milanese M; Arosio B; Vergani C; Crovella S
    Neurobiol Aging; 2010 Jan; 31(1):162-4. PubMed ID: 18433937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
    Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
    Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients.
    Guidi I; Galimberti D; Venturelli E; Lovati C; Del Bo R; Fenoglio C; Gatti A; Dominici R; Galbiati S; Virgilio R; Pomati S; Comi GP; Mariani C; Forloni G; Bresolin N; Scarpini E
    Neurobiol Aging; 2005 Jun; 26(6):789-94. PubMed ID: 15718036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.